Amphastar Pharmaceuticals Inc (AMPH)
41.00
+0.09
(+0.22%)
USD |
NASDAQ |
Apr 24, 16:00
40.98
-0.02
(-0.04%)
After-Hours: 20:00
Amphastar Pharmaceuticals Price to Book Value: 3.084 for April 24, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 24, 2024 | 3.084 |
| April 23, 2024 | 3.077 |
| April 22, 2024 | 3.022 |
| April 19, 2024 | 3.010 |
| April 18, 2024 | 2.907 |
| April 17, 2024 | 3.012 |
| April 16, 2024 | 3.076 |
| April 15, 2024 | 3.067 |
| April 12, 2024 | 2.980 |
| April 11, 2024 | 3.02 |
| April 10, 2024 | 3.012 |
| April 09, 2024 | 3.076 |
| April 08, 2024 | 3.088 |
| April 05, 2024 | 3.143 |
| April 04, 2024 | 3.123 |
| April 03, 2024 | 3.155 |
| April 02, 2024 | 3.183 |
| April 01, 2024 | 3.268 |
| March 28, 2024 | 3.303 |
| March 27, 2024 | 3.274 |
| March 26, 2024 | 3.250 |
| March 25, 2024 | 3.282 |
| March 22, 2024 | 3.287 |
| March 21, 2024 | 3.350 |
| March 20, 2024 | 3.312 |
| Date | Value |
|---|---|
| March 19, 2024 | 3.352 |
| March 18, 2024 | 3.223 |
| March 15, 2024 | 3.238 |
| March 14, 2024 | 3.249 |
| March 13, 2024 | 3.276 |
| March 12, 2024 | 3.321 |
| March 11, 2024 | 3.295 |
| March 08, 2024 | 3.435 |
| March 07, 2024 | 3.517 |
| March 06, 2024 | 3.483 |
| March 05, 2024 | 3.560 |
| March 04, 2024 | 3.511 |
| March 01, 2024 | 3.477 |
| February 29, 2024 | 3.503 |
| February 28, 2024 | 4.117 |
| February 27, 2024 | 4.170 |
| February 26, 2024 | 4.144 |
| February 23, 2024 | 4.017 |
| February 22, 2024 | 3.905 |
| February 21, 2024 | 3.853 |
| February 20, 2024 | 3.943 |
| February 16, 2024 | 4.064 |
| February 15, 2024 | 4.173 |
| February 14, 2024 | 4.129 |
| February 13, 2024 | 4.116 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.535
Minimum
Mar 20 2020
5.389
Maximum
Aug 08 2023
2.894
Average
2.636
Median
Jun 23 2020
Price to Book Value Benchmarks
| Eli Lilly and Co | 64.63 |
| Dentsply Sirona Inc | 1.947 |
| Pacira BioSciences Inc | 1.384 |
| Organon & Co | -- |
| NovaBay Pharmaceuticals Inc | 1.706 |
Price to Book Value Related Metrics
| PE Ratio | 15.89 |
| PS Ratio | 3.372 |
| PEG Ratio | 0.3411 |
| Price to Free Cash Flow | 14.95 |
| Price | 41.00 |
| Earnings Yield | 6.29% |
| Market Cap | 1.972B |
| PEGY Ratio | 0.3411 |
| Operating PE Ratio | 11.03 |
| Normalized PE Ratio | 15.89 |